HUP0004173A2 - Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények - Google Patents

Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények Download PDF

Info

Publication number
HUP0004173A2
HUP0004173A2 HU0004173A HUP0004173A HUP0004173A2 HU P0004173 A2 HUP0004173 A2 HU P0004173A2 HU 0004173 A HU0004173 A HU 0004173A HU P0004173 A HUP0004173 A HU P0004173A HU P0004173 A2 HUP0004173 A2 HU P0004173A2
Authority
HU
Hungary
Prior art keywords
weight
eye
carrier
cyclosporine
composition according
Prior art date
Application number
HU0004173A
Other languages
English (en)
Hungarian (hu)
Inventor
Alexandr Jegorov
Vladimír Matha
Josef Stuchlík
Milan Stuchlík
Original Assignee
Galena, A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galena, A.S. filed Critical Galena, A.S.
Publication of HUP0004173A2 publication Critical patent/HUP0004173A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0004173A 1997-12-30 1998-12-17 Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények HUP0004173A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19974237A CZ287497B6 (cs) 1997-12-30 1997-12-30 Topické oční přípravky s imunosupresivními látkami
PCT/CZ1998/000054 WO1999034830A1 (en) 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents

Publications (1)

Publication Number Publication Date
HUP0004173A2 true HUP0004173A2 (hu) 2001-08-28

Family

ID=5467853

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004173A HUP0004173A2 (hu) 1997-12-30 1998-12-17 Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények

Country Status (12)

Country Link
EP (1) EP1058560A1 (cs)
JP (1) JP2002500200A (cs)
AU (1) AU1481399A (cs)
BG (1) BG104558A (cs)
CA (1) CA2317010A1 (cs)
CZ (1) CZ287497B6 (cs)
HR (1) HRP20000258A2 (cs)
HU (1) HUP0004173A2 (cs)
NO (1) NO20003344D0 (cs)
PL (1) PL341604A1 (cs)
SK (1) SK284246B6 (cs)
WO (1) WO1999034830A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
CA2356382A1 (en) * 1998-12-24 2000-07-06 R-Tech Ueno, Ltd. Agent for treating visual cell function disorder
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
AU2003272471B2 (en) 2002-09-18 2010-10-07 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
AU2004274026A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
WO2006086744A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
CN101605529B (zh) 2006-02-09 2013-03-13 参天制药株式会社 稳定制剂及它们的制备和使用方法
CN103127100A (zh) 2006-03-23 2013-06-05 参天制药株式会社 用于与血管通透性有关的疾病或病症的制剂和方法
DK2948134T3 (da) 2013-01-24 2020-06-02 Palvella Therapeutics Inc Sammensætninger til transdermal indgivelse af mtor-inhibitorer
AU2013384818A1 (en) * 2013-03-27 2015-11-12 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
JP6960937B2 (ja) 2016-03-08 2021-11-05 リビング プルーフ インコーポレイテッド 長期持続性化粧品組成物
CN110520097B (zh) 2017-01-06 2023-10-27 帕尔维拉治疗股份有限公司 Mtor抑制剂的无水组合物及其使用方法
JP7244495B2 (ja) 2017-09-13 2023-03-22 リビング プルーフ インコーポレイテッド 長期持続性の化粧品組成物
WO2019055445A2 (en) 2017-09-13 2019-03-21 Living Proof, Inc. COLOR PROTECTION COMPOSITIONS
WO2019099966A1 (en) 2017-11-20 2019-05-23 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
EP3784711A1 (en) 2018-04-27 2021-03-03 Living Proof, Inc. Long lasting cosmetic compositions
WO2020010073A1 (en) 2018-07-02 2020-01-09 Palvella Therapeutics, Inc. ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents

Also Published As

Publication number Publication date
PL341604A1 (en) 2001-04-23
HRP20000258A2 (en) 2001-04-30
WO1999034830A1 (en) 1999-07-15
CZ287497B6 (cs) 2000-12-13
SK284246B6 (sk) 2004-12-01
EP1058560A1 (en) 2000-12-13
AU1481399A (en) 1999-07-26
CA2317010A1 (en) 1999-07-15
JP2002500200A (ja) 2002-01-08
BG104558A (en) 2001-02-28
NO20003344L (no) 2000-06-27
NO20003344D0 (no) 2000-06-27
SK171798A3 (en) 1999-10-08
CZ423797A3 (cs) 1999-07-14

Similar Documents

Publication Publication Date Title
HUP0004173A2 (hu) Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények
Shen et al. Preparation and ocular pharmacokinetics of ganciclovir liposomes
US5951971A (en) Ophthalmic compositions
Pleyer et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye.
EP2547323B1 (en) Pharmaceutical composition for treatment of increased intraocular pressure
US4115544A (en) Ocular system made of bioerodible esters having linear ether
CN116133639A (zh) 用于治疗炎性疾病的制剂和方法
JP6824270B2 (ja) 生物活性親油性化合物を有するｐｅｇ化脂質ナノ粒子
HK1004520B (en) Ophthalmic compositions containing a cyclosporin
PL201055B1 (pl) Preparat oftalmiczny zawierający cyklosporynę do stosowania miejscowego i zastosowanie cyklosporyny
AU626928B2 (en) Cyclosporin opthalmic compositions
US20030069232A1 (en) Topical treatment of ocular hypertension, glaucoma, ischemic retinopathy and age-related macular degeneration with ophthalmic formulation of dopamine antagonists
KR20150139899A (ko) 지속적인 안구내 방출을 위한 마이크로스피어 약물 전달 시스템
US4173226A (en) Device for administering solid drug particles to an eye
JPH05186333A (ja) 眼用組成物
EP2575854B1 (en) Cyclosporin emulsions
Rahimy et al. Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations
SIEFERT et al. Influence of cyclodextrins on the in vitro corneal permeability and in vivo ocular distribution of thalidomide
EP3970692B1 (en) Lipid-based ophthalmic composition for the treatment of dry eye
AU9643398A (en) Use of flunarizine for the topical treatment of glaucoma
JP2006001948A (ja) 眼科薬送達ビヒクルとしてのサブミクロン乳剤
RU2634267C2 (ru) Водный офтальмологический раствор на основе циклоспорина a
MXPA00006508A (en) Topical ophthalmic preparations containing immunosuppressive agents
HK1183443B (en) Cyclosporin emulsions